During the carcinogenesis of pancreatic cancer, the imperative to exceed a critical threshold of KRAS activation for cellular transformation, combined with the fact that only a subset of KRAS mutant cells progress to malignancy, highlights the involvement of additional, albeit not fully elucidated, regulatory mechanisms. The gene discussed is KRAS; the disease is pancreatic neoplasm.